NCT00936832 2022-08-30Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryFederation Francophone de Cancerologie DigestivePhase 2 Withdrawn